Skip to main content
BSE EXPERIENCE THE NEW
Notices | Media Release | Trading Holidays | BSEPlus | BSE SME | Payments to BSE | Contact us | Careers | FeedBack
BSEINDIA
BSE SENSEX
|
(Indicative Close)
Get Quote
    Corporate Announcement
    Security Code : 532296    Company : GLENMARK    
     
    UpdatesDownload PDF Download XBRL
      Exchange Received Time  28/11/2017 10:14:28         Exchange Disseminated Time   28/11/2017 10:14:36              Time Taken   00:00:08
    Sub: USFDA Audit -Baddi Unit

    We have to inform you that the Baddi unit of Glenmark Pharmaceuticals Limited underwent an US FDA audit from November 6, 2017 to November 11, 2017. The USFDA issued seven observations through the form 483. We are in the midst of providing a comprehensive response to the observations and would be replying to the FDA shortly on the observations.

    At this point in time, we would like to inform you that the Baddi unit contributes approximately 10 percent of the revenue of US sales.
     

    Disclaimer
    Back To Announcements